Evaluate the persistence and immune memory induced by a primary vaccination course with GSK Biologicals’ MenC-TT (1 formulation) % GSK Biologicals’ Hib-MenC-TT (2 formulations) or Meningitec™ in healthy toddlers aged 12-15 mths primed in study 711202/001
Meningococcal Vaccine
Infections, Meningococcal
Phase 2
This is a persistence study of 711202/001. An annotated case report form is not available for this study. A blank case report form will be provided.
June 2015